Creative Medical Technology (CELZ) Competitors $1.97 +0.04 (+2.07%) Closing price 04/25/2025 04:00 PM EasternExtended Trading$1.96 0.00 (-0.25%) As of 04/25/2025 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELZ vs. CLRB, ABP, NRSN, IPA, MEIP, ME, CLDI, ABVC, SYBX, and TXMDShould you be buying Creative Medical Technology stock or one of its competitors? The main competitors of Creative Medical Technology include Cellectar Biosciences (CLRB), Abpro (ABP), NeuroSense Therapeutics (NRSN), ImmunoPrecise Antibodies (IPA), MEI Pharma (MEIP), 23andMe (ME), Calidi Biotherapeutics (CLDI), ABVC BioPharma (ABVC), Synlogic (SYBX), and TherapeuticsMD (TXMD). These companies are all part of the "pharmaceutical products" industry. Creative Medical Technology vs. Cellectar Biosciences Abpro NeuroSense Therapeutics ImmunoPrecise Antibodies MEI Pharma 23andMe Calidi Biotherapeutics ABVC BioPharma Synlogic TherapeuticsMD Creative Medical Technology (NASDAQ:CELZ) and Cellectar Biosciences (NASDAQ:CLRB) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability, community ranking and analyst recommendations. Does the media favor CELZ or CLRB? In the previous week, Cellectar Biosciences had 2 more articles in the media than Creative Medical Technology. MarketBeat recorded 3 mentions for Cellectar Biosciences and 1 mentions for Creative Medical Technology. Cellectar Biosciences' average media sentiment score of 0.34 beat Creative Medical Technology's score of 0.00 indicating that Cellectar Biosciences is being referred to more favorably in the news media. Company Overall Sentiment Creative Medical Technology Neutral Cellectar Biosciences Neutral Which has more volatility and risk, CELZ or CLRB? Creative Medical Technology has a beta of 2, indicating that its share price is 100% more volatile than the S&P 500. Comparatively, Cellectar Biosciences has a beta of 0.67, indicating that its share price is 33% less volatile than the S&P 500. Do insiders & institutionals believe in CELZ or CLRB? 1.4% of Creative Medical Technology shares are held by institutional investors. Comparatively, 16.4% of Cellectar Biosciences shares are held by institutional investors. 1.8% of Creative Medical Technology shares are held by insiders. Comparatively, 3.7% of Cellectar Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is CELZ or CLRB more profitable? Cellectar Biosciences' return on equity of 0.00% beat Creative Medical Technology's return on equity.Company Net Margins Return on Equity Return on Assets Creative Medical TechnologyN/A -63.05% -60.42% Cellectar Biosciences N/A N/A -191.22% Which has better valuation and earnings, CELZ or CLRB? Creative Medical Technology has higher revenue and earnings than Cellectar Biosciences. Creative Medical Technology is trading at a lower price-to-earnings ratio than Cellectar Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCreative Medical Technology$11K313.05-$5.29M-$3.71-0.53Cellectar BiosciencesN/AN/A-$42.77M-$1.33-0.23 Do analysts prefer CELZ or CLRB? Cellectar Biosciences has a consensus target price of $12.50, indicating a potential upside of 3,932.26%. Given Cellectar Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Cellectar Biosciences is more favorable than Creative Medical Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Creative Medical Technology 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Cellectar Biosciences 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the MarketBeat Community believe in CELZ or CLRB? Cellectar Biosciences received 172 more outperform votes than Creative Medical Technology when rated by MarketBeat users. However, 68.93% of users gave Creative Medical Technology an outperform vote while only 53.88% of users gave Cellectar Biosciences an outperform vote. CompanyUnderperformOutperformCreative Medical TechnologyOutperform Votes7168.93% Underperform Votes3231.07% Cellectar BiosciencesOutperform Votes24353.88% Underperform Votes20846.12% SummaryCellectar Biosciences beats Creative Medical Technology on 11 of the 16 factors compared between the two stocks. Get Creative Medical Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELZ vs. The Competition Export to ExcelMetricCreative Medical TechnologyBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.44M$2.91B$5.44B$7.80BDividend YieldN/A1.91%5.43%4.31%P/E Ratio-0.5229.2222.1418.40Price / Sales313.05481.28389.70101.30Price / CashN/A168.6838.2034.62Price / Book0.263.036.664.18Net Income-$5.29M-$72.17M$3.21B$247.71M7 Day PerformanceN/A9.36%6.21%6.61%1 Month Performance-10.86%-3.64%-2.83%-2.22%1 Year Performance-54.40%-21.09%16.43%4.67% Creative Medical Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELZCreative Medical Technology0.5788 of 5 stars$1.97+2.1%N/A-55.4%$3.44M$11,000.00-0.525CLRBCellectar Biosciences2.199 of 5 stars$0.30+4.3%$12.50+4,028.1%-89.7%$13.95MN/A-0.1810ABPAbproN/A$0.27+15.6%$4.00+1,398.1%N/A$13.84M$183,000.000.0015Gap UpHigh Trading VolumeNRSNNeuroSense Therapeutics0.2858 of 5 stars$1.01+1.0%N/A-20.6%$13.80MN/A-1.5810News CoverageIPAImmunoPrecise Antibodies1.957 of 5 stars$0.44+6.9%$4.00+819.5%-63.1%$13.51M$24.00M-0.5680MEIPMEI Pharma1.6109 of 5 stars$2.02+5.8%N/A-32.3%$13.46M$65.30M-0.35100Analyst ForecastME23andMe0.457 of 5 stars$0.50-35.3%N/A-94.6%$13.36M$208.78M-0.03770Gap DownHigh Trading VolumeCLDICalidi Biotherapeutics1.7123 of 5 stars$0.46+5.0%$15.00+3,146.8%N/A$13.15M$50,000.000.0038News CoverageABVCABVC BioPharma0.6357 of 5 stars$0.83-4.7%N/A-38.6%$13.12M$509,788.00-0.9730SYBXSynlogic1.0563 of 5 stars$1.12+5.3%N/A-39.7%$13.05M$8,000.00-0.2780Gap DownTXMDTherapeuticsMD0.5922 of 5 stars$1.11+11.4%N/A-38.5%$12.85M$1.76M0.00420Analyst Forecast Related Companies and Tools Related Companies Cellectar Biosciences Alternatives Abpro Alternatives NeuroSense Therapeutics Alternatives ImmunoPrecise Antibodies Alternatives MEI Pharma Alternatives 23andMe Alternatives Calidi Biotherapeutics Alternatives ABVC BioPharma Alternatives Synlogic Alternatives TherapeuticsMD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELZ) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Creative Medical Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
